Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For clinicians:
- Clinicians who regularly treat some young people with autism spectrum disorder (ASD) as part of their recognised professional role (such as psychologists, counsellors, family therapists, or social workers)
- Clinicians who see young people with ASD referred through Regional Centers, Tricare/NMCSD, or California public schools
- Clinicians who are willing to invite at least one eligible family to participate, with the aim of having at least two families from their practice take part in the study
For young people and their families:
- Boys or girls between 6 and 14 years old who have already been formally diagnosed with ASD by a licensed professional (such as a clinical psychologist or developmental paediatrician), with that diagnosis documented in a report or medical record
- Young people who are newly referred for outpatient services with a clinician who is participating in the study
- Young people whose parent or caregiver completes a standard ASD screening questionnaire (called the SRS-2) and scores above a certain threshold, indicating significant social difficulties consistent with ASD
- Young people who show clinically significant difficulties managing emotions, as measured by a parent-reported questionnaire (called the Brief Problem Monitor), with scores above a set level in either emotional/behavioural problems
- Young people who have a sufficient level of communication ability, as measured by a standardised assessment (the Vineland Adaptive Behavior Scales-3), above a specified minimum score
Who may not be able to join:
- Young people whose additional mental health conditions (for example, symptoms of psychosis) are severe enough to need immediate treatment or require ongoing adjustment of medication at the time of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wood, University of California
Phone: 310-882-0537
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Brief Problem Monitor (BPM)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.